vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and UDR, Inc. (UDR). Click either name above to swap in a different company.

UDR, Inc. is the larger business by last-quarter revenue ($425.8M vs $270.8M, roughly 1.6× HUTCHMED (China) Ltd). UDR, Inc. runs the higher net margin — 44.6% vs 0.7%, a 43.9% gap on every dollar of revenue. On growth, UDR, Inc. posted the faster year-over-year revenue change (0.9% vs -16.5%).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

UDR, Inc. is a leading U.S.-headquartered real estate investment trust specializing in owning, operating, and redeveloping high-quality multifamily residential apartment communities. It operates across major U.S. metropolitan markets, catering to a diverse tenant base including young professionals, families, and middle-to-high income households.

HCM vs UDR — Head-to-Head

Bigger by revenue
UDR
UDR
1.6× larger
UDR
$425.8M
$270.8M
HCM
Growing faster (revenue YoY)
UDR
UDR
+17.5% gap
UDR
0.9%
-16.5%
HCM
Higher net margin
UDR
UDR
43.9% more per $
UDR
44.6%
0.7%
HCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HCM
HCM
UDR
UDR
Revenue
$270.8M
$425.8M
Net Profit
$2.0M
$189.8M
Gross Margin
37.7%
Operating Margin
-13.2%
54.0%
Net Margin
0.7%
44.6%
Revenue YoY
-16.5%
0.9%
Net Profit YoY
-83.6%
147.2%
EPS (diluted)
$0.00
$0.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
UDR
UDR
Q1 26
$425.8M
Q4 25
$270.8M
$433.1M
Q3 25
$431.9M
Q2 25
$277.7M
$425.4M
Q1 25
$324.5M
$421.9M
Q4 24
$422.7M
Q3 24
$420.2M
Q2 24
$305.7M
$415.3M
Net Profit
HCM
HCM
UDR
UDR
Q1 26
$189.8M
Q4 25
$2.0M
$222.9M
Q3 25
$40.4M
Q2 25
$455.0M
$37.7M
Q1 25
$11.9M
$76.7M
Q4 24
$-5.0M
Q3 24
$22.6M
Q2 24
$25.8M
$28.9M
Gross Margin
HCM
HCM
UDR
UDR
Q1 26
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Operating Margin
HCM
HCM
UDR
UDR
Q1 26
54.0%
Q4 25
-13.2%
64.1%
Q3 25
17.7%
Q2 25
-1.3%
18.2%
Q1 25
-5.0%
29.0%
Q4 24
15.7%
Q3 24
16.6%
Q2 24
-9.0%
16.5%
Net Margin
HCM
HCM
UDR
UDR
Q1 26
44.6%
Q4 25
0.7%
51.5%
Q3 25
9.4%
Q2 25
163.8%
8.9%
Q1 25
3.7%
18.2%
Q4 24
-220.5%
Q3 24
5.4%
Q2 24
8.4%
7.0%
EPS (diluted)
HCM
HCM
UDR
UDR
Q1 26
$0.63
Q4 25
$0.00
$0.67
Q3 25
$0.12
Q2 25
$0.52
$0.11
Q1 25
$0.01
$0.23
Q4 24
$-0.01
Q3 24
$0.06
Q2 24
$0.03
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
UDR
UDR
Cash + ST InvestmentsLiquidity on hand
$1.4B
$1.3M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$3.3B
Total Assets
$1.8B
$10.3B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
UDR
UDR
Q1 26
$1.3M
Q4 25
$1.4B
$1.2M
Q3 25
$1.2M
Q2 25
$1.4B
$1.5M
Q1 25
$836.1M
$1.3M
Q4 24
$1.3M
Q3 24
$2.3M
Q2 24
$802.5M
$2.8M
Total Debt
HCM
HCM
UDR
UDR
Q1 26
Q4 25
$93.2M
$5.8B
Q3 25
$5.8B
Q2 25
$93.4M
$5.8B
Q1 25
$82.8M
$5.8B
Q4 24
$5.8B
Q3 24
$5.9B
Q2 24
$82.1M
$5.8B
Stockholders' Equity
HCM
HCM
UDR
UDR
Q1 26
$3.3B
Q4 25
$1.2B
$3.3B
Q3 25
$3.3B
Q2 25
$1.2B
$3.3B
Q1 25
$759.9M
$3.3B
Q4 24
$3.4B
Q3 24
$3.5B
Q2 24
$740.1M
$3.7B
Total Assets
HCM
HCM
UDR
UDR
Q1 26
$10.3B
Q4 25
$1.8B
$10.6B
Q3 25
$10.6B
Q2 25
$1.8B
$10.6B
Q1 25
$1.3B
$10.7B
Q4 24
$10.9B
Q3 24
$11.1B
Q2 24
$1.3B
$11.1B
Debt / Equity
HCM
HCM
UDR
UDR
Q1 26
Q4 25
0.08×
1.77×
Q3 25
1.78×
Q2 25
0.08×
1.74×
Q1 25
0.11×
1.74×
Q4 24
1.69×
Q3 24
1.67×
Q2 24
0.11×
1.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
UDR
UDR
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
4.9%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
UDR
UDR
Q1 26
Q4 25
$8.2M
$902.9M
Q3 25
$234.9M
Q2 25
$-72.9M
$250.3M
Q1 25
$40.3M
$156.2M
Q4 24
$876.8M
Q3 24
$230.3M
Q2 24
$-39.8M
$238.5M
Free Cash Flow
HCM
HCM
UDR
UDR
Q1 26
Q4 25
$3.4M
$650.0M
Q3 25
$164.6M
Q2 25
$-82.2M
$190.1M
Q1 25
$32.5M
$103.2M
Q4 24
$627.0M
Q3 24
$161.3M
Q2 24
$-49.9M
$171.1M
FCF Margin
HCM
HCM
UDR
UDR
Q1 26
Q4 25
1.2%
150.1%
Q3 25
38.1%
Q2 25
-29.6%
44.7%
Q1 25
10.0%
24.5%
Q4 24
148.3%
Q3 24
38.4%
Q2 24
-16.3%
41.2%
Capex Intensity
HCM
HCM
UDR
UDR
Q1 26
4.9%
Q4 25
1.8%
58.4%
Q3 25
16.3%
Q2 25
3.3%
14.2%
Q1 25
2.4%
12.6%
Q4 24
59.1%
Q3 24
16.4%
Q2 24
3.3%
16.2%
Cash Conversion
HCM
HCM
UDR
UDR
Q1 26
Q4 25
4.21×
4.05×
Q3 25
5.81×
Q2 25
-0.16×
6.64×
Q1 25
3.38×
2.04×
Q4 24
Q3 24
10.19×
Q2 24
-1.54×
8.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

UDR
UDR

Rental income$423.3M99%
Joint venture management and other fees$2.5M1%

Related Comparisons